CLINICAL_TRIALS
trial_result
· 2018-12-10
Clinical Trial Update: Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome [Phase 2]
Summary
Phase 2 clinical trial evaluating intranasal insulin for tobacco abstinence syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ajna Hamidovic | Conditions: Tobacco Abstinence Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-12-10